GE HealthCare Technologies Inc. logo
GEHCGE HealthCare Technologies Inc.

Is the earnings yield high or low?

The earnings yield of 4.97% is in line with its 4-year average of 5.13%, around the middle of its 4-year range (3.22%–7.63%).

As of Monday, June 29, 2026. 14.21% below its 12-month average of 5.79%.

Earnings Yield

GEHC Earnings Yield Chart

4.97%
-21.73% 1Y
GEHC Earnings Yield

GEHC Average Earnings Yield Chart

GEHC Earnings Yield

GEHC Current vs Average Earnings Yield Chart

GEHC Earnings Yield Metrics

EARNINGS YIELD

4.97%

EARNINGS YIELD AVG TTM

5.79%

EARNINGS YIELD AVG 3Y

5.05%

EARNINGS YIELD AVG 5Y

N/A

EARNINGS YIELD AVG 10Y

N/A

EARNINGS YIELD AVG 15Y

N/A

EARNINGS YIELD AVG 20Y

N/A

CURRENT VS TTM AVG

-14.21%

CURRENT VS 3Y AVG

-1.59%

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

GEHC Competitors' Earnings Yield

NAMEMARKET CAPEARNINGS YIELDTTM3Y5Y
GE HealthCare Technologies Inc. (GEHC)$29.91B4.97%5.79%5.05%N/A
ResMed Inc. (RMD)vs ›$29.05B5.16%4.03%3.61%2.96%
Zoetis Inc. (ZTS)vs ›$31.88B7.92%4.91%3.60%3.12%
Biogen Inc. (BIIB)vs ›$31.89B4.32%6.16%5.91%5.80%
IQVIA Holdings Inc. (IQV)vs ›$31.90B4.22%3.94%3.58%3.05%
Veeva Systems Inc. (VEEV)vs ›$27.84B3.27%2.37%1.94%1.67%
Centene Corp. (CNC)vs ›$32.44BN/A11.79%7.73%6.10%
DexCom, Inc. (DXCM)vs ›$27.07B3.34%2.64%1.84%1.34%
Medline Inc. (MDLN)vs ›$32.87B3.11%3.21%3.21%3.21%
Moderna, Inc. (MRNA)vs ›$26.69BN/A10.37%11.47%11.47%

Earnings Yield vs P/E Ratio

Earnings Yield

4.97%

EPS ÷ Price

P/E Ratio

20.1

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

  • It expresses earnings relative to share price as a percentage
  • It can be compared with FCF yield and dividend yield
  • It can be compared with bond yields because both are percentages
  • It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Earnings Yield FAQ

What is the earnings yield for GE HealthCare Technologies Inc. (GEHC)?
The earnings yield for GEHC stock is 4.97%.
Is GE HealthCare Technologies Inc.'s earnings yield high or low?
The earnings yield of 4.97% is in line with its 4-year average of 5.13%, around the middle of its 4-year range (3.22%–7.63%).
What is the TTM average earnings yield for GE HealthCare Technologies Inc. (GEHC)?
The TTM average earnings yield for GEHC stock is 5.79%.
What is the 3Y average earnings yield for GE HealthCare Technologies Inc. (GEHC)?
The 3Y average earnings yield for GEHC stock is 5.05%.

GEHC Earnings Yield History

DATEEARNINGS YIELD
2026-06-264.97%
2026-06-255.04%
2026-06-245.04%
2026-06-235.13%
2026-06-225.39%
2026-06-185.31%
2026-06-175.35%
2026-06-165.17%
2026-06-155.05%
2026-06-125.02%
2026-06-115.07%
2026-06-105.13%
2026-06-094.95%
2026-06-085.06%
2026-06-055.06%
2026-06-045.13%
2026-06-035.27%
2026-06-025.27%
2026-06-015.22%
2026-05-295.25%
2026-05-285.20%
2026-05-275.12%
2026-05-265.09%
2026-05-225.09%
2026-05-215.08%
2026-05-205.09%
2026-05-195.31%
2026-05-185.32%
2026-05-155.38%
2026-05-145.22%
2026-05-135.28%
2026-05-125.25%
2026-05-115.30%
2026-05-085.15%
2026-05-075.33%
2026-05-065.30%
2026-05-055.36%
2026-05-045.36%
2026-05-015.36%
2026-04-305.37%
2026-04-295.50%
2026-04-285.33%
2026-04-275.18%
2026-04-245.30%
2026-04-235.22%
2026-04-225.11%
2026-04-215.05%
2026-04-204.92%
2026-04-174.89%
2026-04-164.99%
2026-04-154.97%
2026-04-144.89%
2026-04-134.94%
2026-04-104.99%
2026-04-095.01%
2026-04-084.95%
2026-04-075.24%
2026-04-065.18%
2026-04-025.19%
2026-04-015.07%
2026-03-315.13%
2026-03-305.31%
2026-03-275.27%
2026-03-265.10%
2026-03-255.06%
2026-03-245.14%
2026-03-235.09%
2026-03-205.24%
2026-03-195.19%
2026-03-185.19%
2026-03-175.05%
2026-03-165.06%
2026-03-135.16%
2026-03-125.19%
2026-03-115.03%
2026-03-105.02%
2026-03-094.83%
2026-03-064.91%
2026-03-054.73%
2026-03-044.62%
2026-03-034.67%
2026-03-024.55%
2026-02-274.33%
2026-02-264.35%
2026-02-254.34%
2026-02-244.34%
2026-02-234.35%
2026-02-204.33%
2026-02-194.40%
2026-02-184.40%
2026-02-174.47%
2026-02-134.54%
2026-02-124.64%
2026-02-114.61%
2026-02-104.61%
2026-02-094.61%
2026-02-064.52%
2026-02-054.43%
2026-02-044.42%
2026-02-036.14%
2026-02-026.04%
2026-01-306.13%
2026-01-296.14%
2026-01-286.11%
2026-01-276.02%
2026-01-266.03%
2026-01-236.07%
2026-01-225.91%
2026-01-215.97%
2026-01-206.14%
2026-01-165.92%
2026-01-155.87%
2026-01-145.68%
2026-01-135.71%
2026-01-125.57%
2026-01-095.55%
2026-01-085.49%
2026-01-075.64%
2026-01-065.58%
2026-01-055.69%
2026-01-025.84%
2025-12-315.90%
2025-12-305.81%
2025-12-295.82%
2025-12-265.79%
2025-12-245.80%
2025-12-235.81%
2025-12-225.77%
2025-12-195.84%
2025-12-185.87%
2025-12-175.88%
2025-12-165.89%
2025-12-155.73%
2025-12-125.76%
2025-12-115.62%
2025-12-105.73%
2025-12-095.83%
2025-12-085.82%
2025-12-055.66%
2025-12-045.87%
2025-12-035.79%
2025-12-026.04%
2025-12-016.11%
2025-11-286.05%
2025-11-266.00%
2025-11-256.05%
2025-11-246.18%
2025-11-216.33%
2025-11-206.48%
2025-11-196.69%
2025-11-186.82%
2025-11-176.85%
2025-11-146.62%
2025-11-136.54%
2025-11-126.46%
2025-11-116.59%
2025-11-106.59%
2025-11-076.63%
2025-11-066.53%
2025-11-056.40%
2025-11-046.51%
2025-11-036.50%
2025-10-316.46%
2025-10-306.45%
2025-10-296.25%
2025-10-286.15%
2025-10-276.23%
2025-10-246.25%
2025-10-236.32%
2025-10-226.41%
2025-10-216.41%
2025-10-206.46%
2025-10-176.59%
2025-10-166.65%
2025-10-156.67%
2025-10-146.75%
2025-10-136.79%
2025-10-106.87%
2025-10-096.57%
2025-10-086.49%
2025-10-076.55%
2025-10-066.39%
2025-10-036.37%
2025-10-026.35%
2025-10-016.46%
2025-09-306.50%
2025-09-296.68%
2025-09-266.73%
2025-09-256.83%
2025-09-246.60%
2025-09-236.54%
2025-09-226.53%
2025-09-196.51%
2025-09-186.60%
2025-09-176.37%
2025-09-166.30%
2025-09-156.28%
2025-09-126.39%
2025-09-116.26%
2025-09-106.42%
2025-09-096.20%
2025-09-086.24%
2025-09-056.44%
2025-09-046.58%
2025-09-036.74%
2025-09-026.82%
2025-08-296.62%
2025-08-286.62%
2025-08-276.57%
2025-08-266.59%
2025-08-256.54%
2025-08-226.49%
2025-08-216.67%
2025-08-206.61%
2025-08-196.60%
2025-08-186.67%
2025-08-156.65%
2025-08-146.63%
2025-08-136.48%
2025-08-126.56%
2025-08-116.68%
2025-08-086.78%
2025-08-076.86%
2025-08-066.97%
2025-08-056.90%
2025-08-046.91%
2025-08-016.99%
2025-07-316.84%
2025-07-306.81%
2025-07-296.11%
2025-07-286.11%
2025-07-256.12%
2025-07-246.19%
2025-07-236.15%
2025-07-226.21%
2025-07-216.41%
2025-07-186.25%
2025-07-176.23%
2025-07-166.30%
2025-07-156.39%
2025-07-146.38%
2025-07-116.32%
2025-07-106.21%
2025-07-096.29%
2025-07-086.32%
2025-07-076.37%
2025-07-036.25%
2025-07-026.24%
2025-07-016.25%
2025-06-306.41%
2025-06-276.39%
2025-06-266.35%
2025-06-256.53%
2025-06-246.60%
2025-06-236.68%
2025-06-206.66%
2025-06-186.61%
2025-06-176.68%
2025-06-166.52%
2025-06-136.57%

Showing the most recent 260 of 884 data points. The chart above shows the full history.

About GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.

Chicago, IL
53,000 employees
Healthcare / Medical - Healthcare Information Services
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Peter J. Arduini